CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 10,720 shares (grant or award)
- 4 Grant or award Director acquired 5,789 shares (grant or award)
- 4 Grant or award Director acquired 1,179 shares (grant or award)
- 4 Planned sale President, US Pharma sold 36,827 shares at $7.03 ($258,894)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President, US Pharma gave up 5,260 shares (to pay taxes)
- 4 Shares withheld for taxes President, US Pharma gave up 23,395 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,125 shares (to pay taxes)
- 4 Grant or award Director acquired 1,394 shares (grant or award)
- 4 Grant or award Director acquired 12,677 shares (grant or award)
- 4 Grant or award Director acquired 6,845 shares (grant or award)
- 8-K Event Executive or director change · Regulation FD disclosure
- SD Other Specialized Disclosure
- 4 Grant or award Director acquired 45,871 shares (grant or award)
- 4 Grant or award Director acquired 45,871 shares (grant or award)
- 4 Grant or award Director acquired 45,871 shares (grant or award)
Page 1 of 121 · 2,419 filings